In Clinical Genetic Analyses, Powerful, Fast and Reliable Solution.
Gennext Clinic is a clinical decision support platform that accelerates high-accuracy genetic analysis, phenotype matching, and interpretation processes for rare and inherited diseases.
Accelerates time-consuming analysis workflows in clinical settings
GPU-accelerated variant analysis infrastructure
Secure data processing compliant with data protection regulations
Rare / Inherited Diseases
Advanced modules that simplify the analysis of genetically driven disorders in pediatric and adult patients.
Oncology
Analyses that support treatment decisions through tumor profiling and actionable gene sets.
Gennext Clinical is a genomic analysis platform designed for rare diseases, cancer, and other genetic disorders, focusing on variant analysis, interpretation, and clinical reporting of post-sequencing data (VCF/BAM/FASTQ).
It is a bioinformatics and clinical reporting platform. It does not perform wet-lab procedures and works with sequencing data generated by partner or in-house NGS laboratories.
Common benign variants or incidental findings unrelated to the clinical indication may be excluded or summarized separately, in line with institutional and ethical policies.
Data is stored on encrypted, access-controlled infrastructure compliant with KVKK and, where applicable, GDPR.
The patient is the data owner. Deletion or anonymization requests are handled according to legal regulations.
Only with explicit consent and ethical approval, using the highest possible anonymization level.
Depends on test type, case volume, and scope, and is defined via SLA agreements.
Pricing is typically per test, per case, or via institutional licensing models.
Reports include responsible experts and technical or scientific contact details.
Yes. HL7, FHIR, REST API, and CSV/TSV-based integrations are supported.
Yes, provided quality metrics are met and security requirements are defined.
Optional re-analysis is available using updated databases, literature, and algorithms.